AQUINOX PHARMACEUTICALS INC - COM (AQXP)

CUSIP: 03842B101

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
15,734,762
Share change
+2,009,425
Total reported value
$138,776,000
Price per share
$8.82
Number of holders
35
Value change
+$16,549,758
Number of buys
23
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q1 2016

As of 31 Mar 2016, AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,734,762 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, LLC, Visium Asset Management, LP, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, Boxer Capital, LLC, BLACKROCK ADVISORS LLC, BlackRock Fund Advisors, BlackRock Group LTD, and BlackRock Institutional Trust Company, N.A.. This page lists 35 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.